Dashboard
Manage Tickers

APLTApplied Therapeutics Inc.

Nasdaq www.appliedtherapeutics.com


$ 4.29 $ 0.05 (1.18 %)    

Friday, 26-Apr-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 4.28
$ 4.32
$ 0.00 x 0
$ 0.00 x 0
$ 4.26 - $ 4.44
$ 1.18 - $ 9.39
429,224
na
360.57M
$ 1.26
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-06-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-23-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-12-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-10-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
12 05-11-2021 03-31-2021 10-Q
13 03-18-2021 12-31-2020 10-K
14 11-12-2020 09-30-2020 10-Q
15 08-11-2020 06-30-2020 10-Q
16 05-11-2020 03-31-2020 10-Q
17 03-13-2020 12-31-2019 10-K
18 11-13-2019 09-30-2019 10-Q
19 08-12-2019 06-30-2019 10-Q
20 06-21-2019 03-31-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

rbc-capital-reiterates-outperform-on-applied-therapeutics-maintains-12-price-target
RBC Capital Reiterates Outperform on Appli...
04/11/2024 14:32:02

RBC Capital analyst Brian Abrahams reiterates Applied Therapeutics (NASDAQ:APLT) with a Outperform and maintains $12 price t...

applied-therapeutics-plans-to-present-results-from-phase-3-arise-hf-study-in-diabetic-cardiomyopathy-at-acc-2024
Applied Therapeutics Plans To Present Resu...
04/04/2024 11:25:46

fda-presses-delay-button-for-applied-therapeutics-first-potential-marketed-drug-for-rare-disease
FDA Presses Delay Button For Applied Thera...
04/01/2024 16:30:46

FDA extends the review period for Applied Therapeutics' NDA for govorestat, targeting Classic Galactosemia treatment. The n...

why-doma-holdings-shares-are-trading-higher-by-around-34-here-are-20-stocks-moving-premarket
Why Doma Holdings Shares Are Trading Highe...
04/01/2024 12:08:35

Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transa...

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
04/01/2024 12:08:05

oxford-industries-posts-weak-results-joins-applied-therapeutics-and-other-big-stocks-moving-lower-in-mondays-pre-market-session
Oxford Industries Posts Weak Results, Join...
04/01/2024 09:13:08

U.S. stock futures were higher this morning, with the Dow futures gaining by over 100 points on Monday.

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
03/29/2024 20:30:47

applied-therapeutics-says-fda-has-extended-review-period-for-nda-for-govorestat-at-007-for-treatment-of-classic-galactosemia-by-three-months-pdufa-target-action-date-november-28-2024
Applied Therapeutics Says FDA Has Extended...
03/28/2024 20:32:45

The FDA notified Applied Therapeutics that it required additional time to review supplemental analyses of previously submitted ...

rbc-capital-initiates-coverage-on-applied-therapeutics-with-outperform-rating-announces-price-target-of-12
RBC Capital Initiates Coverage On Applied ...
03/26/2024 12:53:36

RBC Capital analyst Brian Abrahams initiates coverage on Applied Therapeutics (NASDAQ:APLT) with a Outperform rating and ann...

applied-therapeutics-files-prospectus-for-disposition-from-time-to-time-by-selling-stockholders-of-up-to-143m-shares-of-common-stock
Applied Therapeutics Files Prospectus For ...
03/22/2024 20:36:31

-SEC Filing

ubs-maintains-buy-on-applied-therapeutics-raises-price-target-to-13
UBS Maintains Buy on Applied Therapeutics,...
03/15/2024 12:46:14

UBS analyst Esther Rajavelu maintains Applied Therapeutics (NASDAQ:APLT) with a Buy and raises the price target from $12 to ...

eqt-genie-energy-and-other-big-stocks-moving-lower-on-monday
EQT, Genie Energy And Other Big Stocks Mov...
03/11/2024 14:37:32

U.S. stocks were lower, with the Dow Jones index falling more than 150 points on Monday.

ubs-maintains-buy-on-applied-therapeutics-raises-price-target-to-12
UBS Maintains Buy on Applied Therapeutics,...
03/06/2024 17:38:43

UBS analyst Esther Rajavelu maintains Applied Therapeutics (NASDAQ:APLT) with a Buy and raises the price target from $4 to $12.

applied-therapeutics-q4-earnings-insights
Applied Therapeutics: Q4 Earnings Insights
03/06/2024 13:55:06

applied-therapeutics-expects-that-its-cash-and-cash-equivalents-of-499m-combined-with-the-proceeds-from-the-february-2024-private-placement-of-100m-is-expected-to-provide-cash-runway-into-the-first-half-2026
Applied Therapeutics Expects That Its Cash...
03/06/2024 12:24:13

applied-therapeutics-fy-eps-142-beats-144-estimate-sales-999m-miss-1067m-estimate
Applied Therapeutics FY EPS $(1.42) Beats ...
03/06/2024 12:21:25

Applied Therapeutics (NASDAQ:APLT) reported quarterly losses of $(1.42) per share which beat the analyst consensus estimate of ...

applied-therapeutics-said-on-feb-27-2024-co-entered-into-securities-purchase-agreement-for-private-placement-with-select-group-of-accredited-investors-123m-shares-of-cos-common-stock-at-7share
Applied Therapeutics Said On Feb 27, 2024 ...
02/29/2024 22:01:27

-8-K

why-bumble-shares-are-trading-lower-by-12-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Bumble Shares Are Trading Lower By 12%...
02/28/2024 19:02:02

Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.

advance-auto-parts-reports-q4-results-joins-bg-foods-vipshop-adt-and-other-big-stocks-moving-higher-on-wednesday
Advance Auto Parts Reports Q4 Results, Joi...
02/28/2024 16:37:58

U.S. stocks were lower, with the Dow Jones index falling around 100 points on Wednesday.

fda-grants-review-date-for-applied-therapeutics-first-commercial-product-for-rare-metabolic-disorder
FDA Grants Review Date For Applied Therape...
02/28/2024 16:01:20

Applied Therapeutics surges as FDA grants Priority Review to govorestat (AT-007) for Galactosemia treatment. If approved, it wo...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION